Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiniksa Pharmaceuticals International plc logo

CHIEF ACCOUNTING OFFICER Megna Michael R converted options into 11,496 units of Class A Ordinary Share, covered exercise/tax liability with 5,531 units of Class A Ordinary Share, sold $369,380 worth of Class A Ordinary Share (4,600 units at $80.30) as part of a pre-agreed trading plan and was granted 279 units of Class A Ordinary Share, increasing direct ownership by 6% to 29,062 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KNSA· Kiniksa Pharmaceuticals International plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNSA (Kiniksa Pharmaceuticals International plc) and more on Quantisnow.

CHIEF ACCOUNTING OFFICER Megna Michael R converted options into 11,496 units of Class A Ordinary Share, covered exercise/tax liability with 5,531 units of Class A Ordinary Share, sold $369,380 worth of Class A Ordinary Share (4,600 units at $80.30) as part of a pre-agreed trading plan and was granted 279 units of Class A Ordinary Share, increasing direct ownership by 6% to 29,062 units (SEC Form 4) | Quantisnow